Korean J Blood Transfus.  2007 Dec;18(3):269-274.

A Case of Effective Post-centrifugal Plasma Filtration for L-asparaginase-induced Severe Hyperlipidemia

Affiliations
  • 1Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 2Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 3Department of Laboratory Medicine, Ulsan University Hospital, Ulsan, Korea.

Abstract

Hyperlipidemia has been reported in children with acute lymphoblastic leukemiawho have been treated with L-asparaginase alone or in combination with a steroid. Hyperlipidemia caused by L-asparaginase is usuallyreversible after drug discontinuation, and is rarely associated with severe complications. However, the risk of acute pancreatitis is increased if there is a large increase in triglyceride levels. Prompt correction of hyperlipidemia should be considered to prevent this severe complication. We report a case of successful correction of L-asparaginase-associated severe relapsed hyperlipidemia using post-centrifugal plasma filtration (PCPF), a type of selective plasmapheresis. After 3 sessions of PCPF, the serum concentrations of lipids were markedly reduced. The serum concentration for triglyceridewas reduced to 475 mg/dL from 6,298 mg/dL, the total cholesterol level was reduced to 176 mg/dL from 946 mg/dL, and the level of low-density lipoprotein was reduced to 4 mg/dL from 403 mg/dL. One month later, as determined at the outpatient clinic, the lipid levels were normalized. PCPF was effective for clearing severely increased plasma lipids.

Keyword

Hypertriglyceridemia; L-asparaginase; Plasmapheresis; Plasma filtration

MeSH Terms

Ambulatory Care Facilities
Child
Cholesterol
Filtration*
Humans
Hyperlipidemias*
Hypertriglyceridemia
Lipoproteins
Pancreatitis
Plasma*
Plasmapheresis
Triglycerides
Cholesterol
Lipoproteins
Full Text Links
  • KJBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr